Merck, Plaintiffs Fail To Reach Deal In Fosamax Jaw MDL
Merck & Co. Inc. and a group of plaintiffs in multidistrict litigation over jaw injuries allegedly caused by the bone drug Fosamax broke off settlement talks on Wednesday, a day after...To view the full article, register now.
Already a subscriber? Click here to view full article